National complication and cost burden of transurethral resection of bladder tumor for bladder cancer

JJ H. Zhang(Ronald Reagan UCLA Medical Center), Vidit Sharma(University of California, Los Angeles), Brian Hsuan-Cheng Liao(The University of Texas Medical Branch at Galveston), Karim Chamie(University of California, Los Angeles), Stephen B. Williams(Cedars-Sinai Medical Center), Daniel Joyce(Vanderbilt University Medical Center), Stephen A. Boorjian(Mayo Clinic), Yong Shan(The University of Texas Medical Branch at Galveston), Anthony Fadel(Mayo Clinic in Arizona)
Urologic Oncology Seminars and Original Investigations
April 23, 2025
10.1016/j.urolonc.2025.03.004
Cited by 10

Related Papers

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management
|The Journal of Urology|2022|462
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459